These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33720878)

  • 21. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
    Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
    Tozetto-Mendoza TR; Kanunfre KA; Vilas-Boas LS; Sanchez Espinoza EP; Paião HGO; Rocha MC; de Paula AV; de Oliveira MS; Zampelli DB; Vieira JM; Buss L; Costa SF; Sabino EC; Witkin SS; Okay TS; Mendes-Correa MC
    J Virol Methods; 2021 Apr; 290():114064. PubMed ID: 33453299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of dried blood spot sample modifications to two commercially available COVID-19 IgG antibody immunoassays.
    Zava TT; Zava DT
    Bioanalysis; 2021 Jan; 13(1):13-28. PubMed ID: 33319585
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening.
    Srivastava AK; Gupta A; Chauhan D; Meena RC; Sugadev R; Eslavath MR; Gupta H; Karuna ; Singh S; Singh Y; Tiwari RP; Kohli V; Varshney R; Ganju L
    Appl Microbiol Biotechnol; 2022 Sep; 106(18):6225-6238. PubMed ID: 35976427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virological Correlates of IgM-IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens.
    Barreiro P; Candel FJ; Sanz JC; San Román J; Del Mar Carretero M; Pérez-Abeledo M; Ramos B; Viñuela-Prieto JM; Canora J; Martínez-Peromingo FJ; Zapatero A
    Viruses; 2021 May; 13(5):. PubMed ID: 34068703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results.
    Wang H; Wiredja D; Yang L; Bulterys PL; Costales C; Röltgen K; Manalac J; Yee J; Zehnder J; Shi RZ; Boyd SD; Pinsky BA
    Clin Chem; 2021 Jul; 67(7):977-986. PubMed ID: 33720347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of Anti-SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection.
    Sakhi H; Dahmane D; Attias P; Kofman T; Bouvier M; Lapidus N; Fourati S; El Karoui K;
    J Am Soc Nephrol; 2021 May; 32(5):1033-1036. PubMed ID: 33637518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-2.
    Liu W; Liu L; Kou G; Zheng Y; Ding Y; Ni W; Wang Q; Tan L; Wu W; Tang S; Xiong Z; Zheng S
    J Clin Microbiol; 2020 May; 58(6):. PubMed ID: 32229605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms.
    Turbett SE; Anahtar M; Dighe AS; Garcia Beltran W; Miller T; Scott H; Durbin SM; Bharadwaj M; Thomas J; Gogakos TS; Astudillo M; Lennerz J; Rosenberg ES; Branda JA
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33020186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology.
    Steiner S; Schwarz T; Corman VM; Sotzny F; Bauer S; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
    Front Immunol; 2021; 12():687449. PubMed ID: 34322120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference in levels of SARS-CoV-2 S1 and S2 subunits- and nucleocapsid protein-reactive SIgM/IgM, IgG and SIgA/IgA antibodies in human milk.
    Demers-Mathieu V; Do DM; Mathijssen GB; Sela DA; Seppo A; Järvinen KM; Medo E
    J Perinatol; 2021 Apr; 41(4):850-859. PubMed ID: 32873904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-throughput multiplexed microfluidic device for COVID-19 serology assays.
    Rodriguez-Moncayo R; Cedillo-Alcantar DF; Guevara-Pantoja PE; Chavez-Pineda OG; Hernandez-Ortiz JA; Amador-Hernandez JU; Rojas-Velasco G; Sanchez-Muñoz F; Manzur-Sandoval D; Patino-Lopez LD; May-Arrioja DA; Posadas-Sanchez R; Vargas-Alarcon G; Garcia-Cordero JL
    Lab Chip; 2021 Jan; 21(1):93-104. PubMed ID: 33319882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan.
    Hibino M; Watanabe S; Tobe S; Maeda K; Horiuchi S; Nishiguchi S; Iwase A; Uryu K; Kobayashi S; Kondo T
    Respir Investig; 2022 Mar; 60(2):256-263. PubMed ID: 34924308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays.
    Bohn MK; Hall A; Wilson S; Taher J; Sepiashvili L; Adeli K
    Clin Chem Lab Med; 2021 May; 59(6):e235-e237. PubMed ID: 33577725
    [No Abstract]   [Full Text] [Related]  

  • 36. A Cell-Based ELISA to Improve the Serological Analysis of Anti-SARS-CoV-2 IgG.
    Zarletti G; Tiberi M; De Molfetta V; Bossù M; Toppi E; Bossù P; Scapigliati G
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33171590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019.
    Xiang F; Wang X; He X; Peng Z; Yang B; Zhang J; Zhou Q; Ye H; Ma Y; Li H; Wei X; Cai P; Ma WL
    Clin Infect Dis; 2020 Nov; 71(8):1930-1934. PubMed ID: 32306047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of antigens expressed in Nicotiana benthamiana plant and Escherichia coli for the SARS-CoV-2 IgG antibody detection by ELISA.
    Fogaça MBT; Lopes-Luz L; Saavedra DP; de Oliveira NKAB; Jesus Sousa MB; Perez JDP; de Andrade IA; Crispim GJB; Pinto LDS; Ferreira MRA; Ribeiro BM; Nagata T; Conceição FR; Stefani MMA; Bührer-Sékula S
    J Virol Methods; 2024 Sep; 329():114969. PubMed ID: 38834144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Nucleocapsid protein triggers the main humoral immune response in COVID-19 patients.
    Smits VAJ; Hernández-Carralero E; Paz-Cabrera MC; Cabrera E; Hernández-Reyes Y; Hernández-Fernaud JR; Gillespie DA; Salido E; Hernández-Porto M; Freire R
    Biochem Biophys Res Commun; 2021 Mar; 543():45-49. PubMed ID: 33515911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.
    Bolotin S; Tran V; Osman S; Brown KA; Buchan SA; Joh E; Deeks SL; Allen VG
    J Infect Dis; 2021 Apr; 223(8):1334-1338. PubMed ID: 33400794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.